- Asia-Pacific emerging as the fastest-growing region for clinical trial outsourcing, with India positioned at the center of that shift
- Cost-competitive infrastructure without compromising data quality or regulatory rigor
- Rethinking the strategy: from transactional to strategic
- Overcoming challenges around implementation and use of a new IRT system
- How to leverage your IRT systems effectively to get the most out of your technology
- Selecting an IRT vendor that meets your needs: essential factors and considerations in supplier selection
- Exploring the key factors driving increased clinical trial activity in 2026
- Discover the evolving clinical trial landscape and the opportunities it presents for suppliers and service providers this year
- See how this has shaken up the biopharma competitive landscape and how this will affect the clinical trial supply chain
- Where rare infectious disease trial activity is growing/declining and which indications are driving this
- Geographic shifts in where trials are being conducted and emerging locations to watch
- Benchmarking trial size, duration, sites/countries and other operational metrics against industry standards
- How trial designs are evolving, including adaptive/platform approaches and strain-agnostic development
- What the current pipeline and data suggest for 2027 and beyond
- Building sustainable long-term follow-up strategies
- Keeping patients engaged over many years
- Using registries and real-world data effectively
- Preparing sites for extended study commitments
